Characterization of a Novel Third-Generation Anti-CD24-CAR against Ovarian Cancer

Novel therapeutic approaches against ovarian cancer (OC) are urgently needed because of its high rate of recurrence even after extensive surgery and multi-agent chemotherapy. We aimed to develop a novel anti-CD24 chimeric antigen receptor (CAR) as an immunotherapeutic approach against OC cells and c...

Descripción completa

Detalles Bibliográficos
Autores principales: Klapdor, Rüdiger, Wang, Shuo, Morgan, Michael, Dörk, Thilo, Hacker, Ulrich, Hillemanns, Peter, Büning, Hildegard, Schambach, Axel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6387114/
https://www.ncbi.nlm.nih.gov/pubmed/30717444
http://dx.doi.org/10.3390/ijms20030660

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6387114/
https://www.ncbi.nlm.nih.gov/pubmed/30717444
http://dx.doi.org/10.3390/ijms20030660

Ejemplares similares